Message from David Pidduck, President and CEO Purdue Pharma (Canada)

September 25, 2017

On September 25, 2017, I was appointed to the position of President & CEO of Purdue Pharma (Canada). I look forward to leading this exceptional organization as we continue pursue our mission of developing and providing innovative medicines for patients and health care professionals and of supporting quality education for the safe use of our products.

I do this with a strong and capable leadership team and employee base 400 strong who are equally committed to research, develop, produce and commercialize necessary medicines for the treatment of pain, ADHD, chemotherapy-induced nausea and vomiting (CINV), various ophthalmic conditions; OTC products; and beyond.

We have been passionately committed to improving health and quality of life for Canadians for over 60 years and our collective commitment to doing the right thing remains steadfast.

Over the coming days and months, I will focus on connecting with colleagues, physicians, partners and other stakeholders as we continue to deliver on our current priorities, making a positive contribution to healthcare in Canada and on the lives of the patients we serve.

David Pidduck
President & CEO, Purdue Pharma (Canada)